Related references
Note: Only part of the references are listed.Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria
Sanne Franzen et al.
ALZHEIMERS & DEMENTIA (2022)
Alaska Native elders’ cultural beliefs, practices, and values: The case for culturally informed holistic dementia care
Maria Christina Crouch et al.
Alzheimers & Dementia (2022)
Reproducibility and repeatability of magnetic resonance imaging in dementia
Catherine A. Morgan et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2022)
Novel Targets for Alzheimer's Disease: A View Beyond Amyloid
William J. Ray et al.
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021 (2021)
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative
Thomas K. Karikari et al.
MOLECULAR PSYCHIATRY (2021)
Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau
Sruti Rayaprolu et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Tailoring recruitment message content to reach diverse communities for AD research participation
Dorothy Farrar Edwards et al.
Alzheimers & Dementia (2021)
The screening and enrollment of underrepresented ethnoracial and educational populations in the Alzheimer's Disease Neuroimaging Initiative
Miriam T Ashford et al.
Alzheimers & Dementia (2021)
Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Meng-Shan Tan et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative
Anna Zettergren et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia
Catherine A. Morgan et al.
SCIENTIFIC REPORTS (2021)
Arterial Stiffening Moderates the Relationship Between Type-2 Diabetes Mellitus and White Matter Hyperintensity Burden in Older Adults With Mild Cognitive Impairment
Madeleine L. Werhane et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis
Kristopher M. Kirmess et al.
CLINICA CHIMICA ACTA (2021)
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Itziar de Rojas et al.
NATURE COMMUNICATIONS (2021)
Differences in the potential for dementia prevention between major ethnic groups within one country: A cross sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand
Etuini Ma'u et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Measuring water exchange across the blood-brain barrier using MRI
Ben R. Dickie et al.
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2020)
Relative Validity and Reproducibility of a Short Food Frequency Questionnaire to Assess Nutrient Intakes of New Zealand Adults
Cecilia Ho Yan Sam et al.
NUTRIENTS (2020)
The Regulation of microRNAs in Alzheimer's Disease
Xianjuan Kou et al.
FRONTIERS IN NEUROLOGY (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
Tracy R. Melzer et al.
FRONTIERS IN NEUROLOGY (2019)
Incidence of Dementia and Alzheimer Disease Over Time: A Meta-Analysis
Sujuan Gao et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set
Christian Puzo et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Alzheimer's disease is neither Alzheimer's clinical syndrome nor dementia
William Jagust et al.
ALZHEIMERS & DEMENTIA (2019)
Blood-based biomarkers for Alzheimer's disease-An update
Henrik Zetterberg
JOURNAL OF NEUROSCIENCE METHODS (2019)
An Updated Recommendation for Multiple Comparisons
Derek C. Sauder et al.
ADVANCES IN METHODS AND PRACTICES IN PSYCHOLOGICAL SCIENCE (2019)
An Update on Blood-Based Markers of Alzheimer's Disease Using the SiMoA Platform
Danni Li et al.
NEUROLOGY AND THERAPY (2019)
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Ronald C. Petersen et al.
NEUROLOGY (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia
Lei Yu et al.
ANNALS OF NEUROLOGY (2018)
Do community-dwelling Maori and Pacific peoples present with dementia at a younger age and at a later stage compared with NZ Europeans?
Sarah Cullum et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Precision pharmacology for Alzheimer's disease
Harald Hampel et al.
PHARMACOLOGICAL RESEARCH (2018)
The Physiological Roles of Amyloid-beta Peptide Hint at New Ways to Treat Alzheimer's Disease
Holly M. Brothers et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
The genetic risk of Alzheimer's disease beyond APOE ε4: systematic review of Alzheimer's genetic risk scores
Hannah Stocker et al.
TRANSLATIONAL PSYCHIATRY (2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2018)
A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
Tenielle Porter et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Are the brain's vascular and Alzheimer pathologies additive or interactive?
Rebecca Koncz et al.
CURRENT OPINION IN PSYCHIATRY (2018)
Changes in intracranial venous blood flow and pulsatility in Alzheimer's disease: A 4D flow MRI study
Leonardo A. Rivera-Rivera et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Rebecca F. Gottesman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers
Emma Lawrence et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Dementia prevention, intervention, and care
Gill Livingston et al.
LANCET (2017)
The changing prevalence and incidence of dementia over time - current evidence
Yu-Tzu Wu et al.
NATURE REVIEWS NEUROLOGY (2017)
Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
Shorena Janelidze et al.
JAMA NEUROLOGY (2017)
Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging
Yeonsil Moon et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis
Y. Iturria-Medina et al.
NATURE COMMUNICATIONS (2016)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
Prashanthi Vemuri et al.
BRAIN (2015)
Common polygenic variation enhances risk prediction for Alzheimer's disease
Valentina Escott-Price et al.
BRAIN (2015)
UK Biobank comes of age
Simon G. Thompson et al.
LANCET (2015)
Amyloid biomarkers in Alzheimer's disease
Kai Blennow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Alzheimer's disease
Colin L. Masters et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen et al.
ALZHEIMERS & DEMENTIA (2014)
Mild cognitive impairment: a concept in evolution
R. C. Petersen et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Validation of the Addenbrooke's Cognitive Examination III in Frontotemporal Dementia and Alzheimer's Disease
Sharpley Hsieh et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Distinguishing Subtypes in Primary Progressive Aphasia: Application of the Sydney Language Battery
Sharon Savage et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Risk Factors for β-Amyloid Deposition in Healthy Aging
Karen M. Rodrigue et al.
JAMA NEUROLOGY (2013)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner et al.
Alzheimers & Dementia (2011)
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A. Ellis et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores
Sid E. O'Bryant et al.
ARCHIVES OF NEUROLOGY (2008)
The measurement of Everyday Cognition (ECog): Scale development and psychometric properties
Sarah Tomaszewski Farias et al.
NEUROPSYCHOLOGY (2008)
Assessment of complex mental activity across the lifespan: development of the Lifetime of Experiences Questionnaire (LEQ)
Michael J. Valenzuela et al.
PSYCHOLOGICAL MEDICINE (2007)
Development and validation of the geriatric anxiety inventory
Nancy A. Pachana et al.
INTERNATIONAL PSYCHOGERIATRICS (2007)
The California Verbal Learning Test - second edition: Test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms
Steven Paul Woods et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Reliability, validity and reference values of the Zarit Burden Interview for assessing informal caregivers of community-dwelling older persons with dementia
R Hébert et al.
CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT (2000)
Share Paper
